NCT01412762 Measuring Patient Expectations for Thyroid Surgery Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01407263 Trial of Modifications to Radical Prostatectomy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01404949 Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy Status COMPLETED Phase PHASE2
NCT01399918 Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE2
NCT01393509 The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT01393483 Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) Status COMPLETED Phase N/A
NCT01392222 Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others Status COMPLETED Phase N/A
NCT01392209 Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT01386411 Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer Status COMPLETED Phase N/A
NCT01383759 Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis Status COMPLETED Phase NA
NCT01380145 MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE1
NCT01379287 Dose-Escalation Safety and Pharmacokinetic Study of Iso-Fludelone in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01356251 Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma Status COMPLETED Phase NA
NCT01355926 A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery Status COMPLETED Phase NA
NCT01354951 Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer Status TERMINATED Phase PHASE2
NCT01351623 Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01349647 Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid Status COMPLETED Phase PHASE1
NCT01345175 Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer Status COMPLETED Phase PHASE3
NCT01339052 Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT01332786 Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia Status COMPLETED Phase PHASE1